BIO07024 2019 Biopharmaceutical Validation
This course aims to provide the student with a general understanding of the various aspects of process and support systems validation for the manufacturing of modern biopharmaceuticals. It will also deal with the various risks inherent in bioprocessing technologies and how the application of effective validation systems and methodologies assists in the control and management of such risks.
Learning Outcomes
On completion of this module the learner will/should be able to;
Describe the main stages involved in a systematic approach to the validation of bioprocessing systems.
Describe the main steps involved in the process validation of biopharmaceutical cell culture processing.
Describe the main steps involved in the process validation of biopharmaceutical protein purification and fill-finish operation.
Describe the validation approach for viral control technologies for biopharmaceutical manufacture.
Perform some research on a relevant topic and analyse, evaluate and draw conclusions accordingly.
Communicate and explain scientific data relating to biopharmaceutical validation.
Teaching and Learning Strategies
N/A
Module Assessment Strategies
Continuous Assessment of Course Work - 50% of marks.
End of term final exam - 50% of marks.
Repeat Assessments
N/A
Indicative Syllabus
An overview of Validation Systems and Methodologies for Biopharmaceutical Manufacture.
Risk Identification and Risk Assessment for Biopharmaceutical Manufacture.
Process Validation for Upstream Cell Culture Processing.
Process Validation for Downstream Protein Purification and Fill-finish.
Validation Methodology for Viral Control of Biopharmaceuticals.
Validation life cycle
Equipment qualficiation and V model
Coursework & Assessment Breakdown
Coursework Assessment
Title | Type | Form | Percent | Week | Learning Outcomes Assessed | |
---|---|---|---|---|---|---|
1 | Multiple Choice Questions | Coursework Assessment | Multiple Choice/Short Answer Test | 10 % | Week 5 | 1,2,3,4 |
2 | Assignment | Coursework Assessment | Project | 30 % | End of Semester | 5,6 |
3 | Multiple Choice Questions | Coursework Assessment | Multiple Choice/Short Answer Test | 10 % | Week 12 | 3,4,5,6 |
End of Semester / Year Assessment
Title | Type | Form | Percent | Week | Learning Outcomes Assessed | |
---|---|---|---|---|---|---|
1 | Final Exam | Final Exam | Closed Book Exam | 50 % | End of Term | 1,2,3,4 |
Part Time Mode Workload
Type | Location | Description | Hours | Frequency | Avg Workload |
---|---|---|---|---|---|
Lecture | Not Specified | Online Lecture | 1 | Weekly | 1.00 |
Directed Learning | Not Specified | Course Notes etc. | 3 | Weekly | 3.00 |
Independent Learning | UNKNOWN | Mini Research | 3 | Weekly | 3.00 |
Module Resources
‘Biotechnology - Quality Assurance and Validation' by K.E Avis, C.M.Wagner and V.L. Wu. Interpharm / CRC 1999. ISBN - 1-57491-089-2.
PDA Journal of Pharmaceutical Science and Technology. Technical Report No. 42: ‘Process Validation of Protein Manufacturing'.
‘Pharmaceutical Biotechnology - Concepts and Applications' by Gary Walsh. Wiley Publications. 2007. ISBN - 978-0-470-01244-4.
'Bioprocess Engineering - Basic Concepts' by Shuler,M.L. and Kargi F. Prentice-Hall. 2002. ISBN - 0-13-081908-5.
N/A
N/A
None
None